Indomethacin
INDOCIN
Nonsteroidal Anti-inflammatory Drug
NADAC/unit
$0.0961
No Shortage
Tier 1: 59.9%
PA Req: 24.9%
16 Manufacturers
22 ANDAs
Indomethacin reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis.
vs. brand INDOCIN: Generic saves up to 99% per unit
Market Intelligence
2025-06-11 Class II Recall: Amerisource Health Services LLC
2025-05-28 Class II Recall: KVK Tech, Inc.
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2024-09-04 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2023-12-06 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
AMNEAL PHARMACEUTICALSAMNEAL PHARMACEUTICALS LLCANNORA PHARMA PRIVATE LTDAVANTHI INCCHARTWELL MOLECULES LLCCHARTWELL RX SCIENCES LLCCOSETTE PHARMACEUTICALS INCFRESENIUS KABI USA LLCGLENMARK PHARMACEUTICALS LTDHETERO LABS LTD UNIT IIIHIKMA PHARMACEUTICALS USA INCNOVAST LABORATORIES LTDNOVITIUM PHARMA LLCSANDOZ INCZYDUS LIFESCIENCES GLOBAL FZEZYDUS LIFESCIENCES LTDZYDUS PHARMACEUTICALS USA INCZYLA LIFE SCIENCES US INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.